October 25, 2014 12:29 PM ET

Pharmaceuticals

Company Overview of Ivrea Pharmaceuticals, Inc.

Company Overview

Ivrea Pharmaceuticals, Inc., a specialty pharmaceutical company, provides clinical development and commercialization of prescription pharmaceuticals for the treatment of dermatologic conditions, such as onychomychosis, acne, and photodamage. Its products include IVR 101/102 which combines gels with known fungicidal active ingredients, thus creating dermatological prescription products for the treatment of onychomycosis; and IVR 103 which utilizes proprietary platform technology to reduce the level of irritation associated with all trans retinoic acid (also called tretinoin) while treating acne. The company was founded in 2005 and is based in Quincy, Massachusetts.

216 Ricciuti Drive

Quincy, MA 02169

United States

Founded in 2005

Phone:

617-376-2491

Key Executives for Ivrea Pharmaceuticals, Inc.

Chief Executive Officer
Age: 56
Co-Founder
Co-Founder and Chief Technical Officer
Chief Financial Officer
Vice President of R & D
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
MacuSight, Inc. United States
L.N.K. International Inc. United States
GMP Laboratories of America, Inc. United States
Compound Healthcare, Inc. United States
LSK BioPartners, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ivrea Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.